JP2024518792A5 - - Google Patents

Info

Publication number
JP2024518792A5
JP2024518792A5 JP2023570181A JP2023570181A JP2024518792A5 JP 2024518792 A5 JP2024518792 A5 JP 2024518792A5 JP 2023570181 A JP2023570181 A JP 2023570181A JP 2023570181 A JP2023570181 A JP 2023570181A JP 2024518792 A5 JP2024518792 A5 JP 2024518792A5
Authority
JP
Japan
Prior art keywords
amino
carboxamide
sulfonyl
pyridine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023570181A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518792A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/029112 external-priority patent/WO2022241173A1/en
Publication of JP2024518792A publication Critical patent/JP2024518792A/ja
Publication of JP2024518792A5 publication Critical patent/JP2024518792A5/ja
Pending legal-status Critical Current

Links

JP2023570181A 2021-05-14 2022-05-13 置換ヘテロ環化合物 Pending JP2024518792A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163188498P 2021-05-14 2021-05-14
US63/188,498 2021-05-14
US202263340629P 2022-05-11 2022-05-11
US63/340,629 2022-05-11
PCT/US2022/029112 WO2022241173A1 (en) 2021-05-14 2022-05-13 Substituted heterocyclic compounds

Publications (2)

Publication Number Publication Date
JP2024518792A JP2024518792A (ja) 2024-05-02
JP2024518792A5 true JP2024518792A5 (enExample) 2025-05-21

Family

ID=81927880

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023570181A Pending JP2024518792A (ja) 2021-05-14 2022-05-13 置換ヘテロ環化合物

Country Status (5)

Country Link
US (1) US20250066322A1 (enExample)
EP (1) EP4337650A1 (enExample)
JP (1) JP2024518792A (enExample)
KR (1) KR20240008337A (enExample)
WO (1) WO2022241173A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN122520625A (zh) 2020-12-22 2026-08-07 益方生物科技(上海)股份有限公司 杂芳基化合物及其制备方法和用途
US12668594B2 (en) 2020-12-23 2026-06-30 Sudo Biosciences Limited TYK2 inhibitors and uses thereof
IL305119A (en) 2021-02-19 2023-10-01 Sudo Biosciences Ltd Tyk2 inhibitors and uses thereof
TW202302583A (zh) 2021-02-19 2023-01-16 英商蘇多生物科學有限公司 Tyk2抑制劑及其用途
KR20230159421A (ko) 2021-02-19 2023-11-21 수도 바이오사이언시즈 리미티드 Tyk2 억제제 및 이의 용도
US20240317718A1 (en) * 2021-05-14 2024-09-26 Bristol-Myers Squibb Company Substituted heterocyclic compounds
KR20240008338A (ko) * 2021-05-14 2024-01-18 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물
KR20240007242A (ko) * 2021-05-14 2024-01-16 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물
CN117263913A (zh) 2022-06-20 2023-12-22 益方生物科技(上海)股份有限公司 杂芳基化合物、固体形式、制备方法及其用途
CN118812511A (zh) * 2023-04-21 2024-10-22 浙江文达医药科技有限公司 作为tyk2抑制剂的杂环化合物及合成和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20220766T1 (hr) 2012-11-08 2022-09-16 Bristol-Myers Squibb Company Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora
MY202167A (en) * 2017-11-21 2024-04-12 Bristol Myers Squibb Co Sulfone pyridine alkyl amide-substituted heteroaryl compounds
RS66346B1 (sr) * 2018-10-22 2025-01-31 Alumis Inc Inhibitori tyk2 i njihova upotreba
PE20250262A1 (es) * 2021-05-14 2025-01-29 Bristol Myers Squibb Co Compuestos heterociclicos sustituidos
US20240317718A1 (en) * 2021-05-14 2024-09-26 Bristol-Myers Squibb Company Substituted heterocyclic compounds
KR20240008338A (ko) * 2021-05-14 2024-01-18 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물
KR20240007242A (ko) * 2021-05-14 2024-01-16 브리스톨-마이어스 스큅 컴퍼니 치환된 헤테로시클릭 화합물

Similar Documents

Publication Publication Date Title
US11912686B2 (en) LPA receptor antagonists and uses thereof
US11572374B2 (en) N-cyano-7-azanorbornane derivatives and uses thereof
TWI920639B (zh) Shp2之八氫環戊烷并[c]吡咯別構抑制劑
TWI639596B (zh) 流感病毒複製之抑制劑
KR101910720B1 (ko) 키나제 억제제로서의 아미노헤테로아릴 벤즈아미드
AU2019201480A1 (en) Heterocyclic amides as kinase inhibitors
AU2015217788B2 (en) Benzimidazol-2-amines as mIDH1 inhibitors
JP2019533694A5 (enExample)
JP2022551185A (ja) イソインドリノン化合物
CA3105748A1 (en) Pyridazine compounds for inhibiting nav1.8
NL1026327C2 (nl) 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten.
JP2024518555A5 (enExample)
US9776962B2 (en) Aromatic compounds with GPR40 agonistic activity
CN103596937B (zh) 取代的苯甲酰胺衍生物
JP5848698B2 (ja) 新規アミドおよびアミジン誘導体ならびにこれらの使用
EP3164396B1 (en) Cyclohexen-1-yl-pyridin-2-yl-1h-pyrazole-4-carboxylic acid derivatives and the use thereof as soluble guanylate cyclase activators
JP2015503529A5 (enExample)
CA2418868A1 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
JP2024520657A5 (enExample)
US20150344429A1 (en) Pyridine-2-amides useful as cb2 agonists
JP2024518791A5 (enExample)
CA2564994A1 (en) Substituted morpholine compounds for the treatment of central nervous system disorders
JP2020502058A5 (enExample)
EA031041B1 (ru) Соединения 2,3,4,5-тетрагидропиридин-6-амин и 3,4-дигидро-2h-пиррол-5-амин - ингибиторы бета-секретазы
JP2023526791A5 (enExample)